<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00130377</url>
  </required_header>
  <id_info>
    <org_study_id>0506137</org_study_id>
    <nct_id>NCT00130377</nct_id>
  </id_info>
  <brief_title>Evaluation of the Treatment of Thoracic &amp; Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com</brief_title>
  <official_title>Biological Cell Therapy for the Treatment of Patients With Thoracic &amp; Cardiovascular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amit N. Patel MD MS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amit, Patel N, M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is the clinical registry of cell based therapies that is available to researchers around
      the world. The registry is web based. All researches must provide IRB approval to the
      coordinating site- University of Utah in order to obtain access to the registry. The are
      predetermined case report forms for cardiovascular diseases that are currently in clinical
      trials- including demographics, safety, and possible efficacy end-points. All investigators
      have access to their own data. The servers are U.S. HIPPA compliant and protected with secure
      back-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical cell registry includes data on thoracic and cardiovascular diseases including:

      Acute myocardial infarction, Chronic Angina, Heart Failure, Wound Healing including Sternal,
      Peripheral Arterial Disease, Critical Limb Ischemia, Type 2 Diabetes, COPD, Asthma.
      Neurological disorders registry is available to specifics sites if requested. Our own
      biological data at the University of Utah including co-localized data with Society of
      Thoracic Surgeons also is a part of this program. Cell based therapies that are autologous
      and allogeneic are included in the registry
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2002</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety - MACE - Death, Readmission, Reintervention</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cardiovascular System Diseases (&amp; [Cardiac])</condition>
  <arm_group>
    <arm_group_label>cell therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient receiving active biologic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patient receiving placebo or standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>cell therapy</intervention_name>
    <description>autologous or allogeneic cells</description>
    <arm_group_label>cell therapy</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;=18 years old

          -  Approved consent to be enrolled in trial/registry

        Exclusion Criteria:

          -  Prior malignancy in the 5 years before treatment in this study (other than curatively
             treated carcinoma in-situ of the cervix or non-melanoma skin cancer)

          -  Inability or unwillingness to comply with the treatment protocol, follow-up, research
             tests, or give consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amit N. Patel, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amit N. Patel, MD, MS</last_name>
    <email>amit.patel@hsc.utah.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amit N Patel, MD,MS</last_name>
    <email>amit.patel@hsc.utah.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amit Patel, MD MS</last_name>
      <email>amit.patel@hsc.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kristin Kolsch</last_name>
      <email>kristin.kolsch@hsc.utah.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Amit Patel, MDMS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lin F, Josephs SF, Alexandrescu DT, Ramos F, Bogin V, Gammill V, Dasanu CA, De Necochea-Campion R, Patel AN, Carrier E, Koos DR. Lasers, stem cells, and COPD. J Transl Med. 2010 Feb 16;8:16. doi: 10.1186/1479-5876-8-16. Review.</citation>
    <PMID>20158898</PMID>
  </reference>
  <reference>
    <citation>Bruckner BA, Ghodsizad A, Loebe M, Beyer E, Ramchandani M, Ruhparwar A, Karck M, Burchardt ER, Patel AN, Reardon M. Surgical stem cell therapy for advanced heart failure patients. Methodist Debakey Cardiovasc J. 2009;5(2):13-7. Review.</citation>
    <PMID>20073160</PMID>
  </reference>
  <reference>
    <citation>Patel AN, Sherman W. Cardiac stem cell therapy: advances from 2008. Cell Transplant. 2009;18(3):243-4. doi: 10.3727/096368909788534960.</citation>
    <PMID>19558772</PMID>
  </reference>
  <reference>
    <citation>Sherman W, Mazouz C, Deans R, Patel AN. Commercialization of trials for peripheral artery disease. Cytotherapy. 2011 Nov;13(10):1157-61. doi: 10.3109/14653249.2011.620795. Review.</citation>
    <PMID>21999371</PMID>
  </reference>
  <reference>
    <citation>Benoit E, O'Donnell TF Jr, Iafrati MD, Asher E, Bandyk DF, Hallett JW, Lumsden AB, Pearl GJ, Roddy SP, Vijayaraghavan K, Patel AN. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. J Transl Med. 2011 Sep 27;9:165. doi: 10.1186/1479-5876-9-165.</citation>
    <PMID>21951607</PMID>
  </reference>
  <reference>
    <citation>Tuma J, Fernández-Viña R, Carrasco A, Castillo J, Cruz C, Carrillo A, Ercilla J, Yarleque C, Cunza J, Henry TD, Patel AN. Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina. J Transl Med. 2011 Oct 26;9:183. doi: 10.1186/1479-5876-9-183.</citation>
    <PMID>22029669</PMID>
  </reference>
  <results_reference>
    <citation>Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HC Jr, Kormos R, Benetti F. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg. 2005 Dec;130(6):1631-8. Epub 2005 Oct 26.</citation>
    <PMID>16308009</PMID>
  </results_reference>
  <results_reference>
    <citation>Patel AN, Mittal S, Turan G, Winters AA, Henry TD, Ince H, Trehan N. REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure. Stem Cells Transl Med. 2015 Sep;4(9):1021-7. doi: 10.5966/sctm.2015-0070. Epub 2015 Jul 27.</citation>
    <PMID>26217065</PMID>
  </results_reference>
  <results_reference>
    <citation>Patel AN, Silva F, Winters AA. Stem cell therapy for heart failure. Heart Fail Clin. 2015 Apr;11(2):275-86. doi: 10.1016/j.hfc.2014.12.006. Review.</citation>
    <PMID>25834975</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2005</study_first_submitted>
  <study_first_submitted_qc>August 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2005</study_first_posted>
  <last_update_submitted>January 17, 2018</last_update_submitted>
  <last_update_submitted_qc>January 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Amit, Patel N, M.D.</investigator_affiliation>
    <investigator_full_name>Amit N. Patel MD MS</investigator_full_name>
    <investigator_title>Amit Patel</investigator_title>
  </responsible_party>
  <keyword>Stem Cell</keyword>
  <keyword>Heart</keyword>
  <keyword>Lung</keyword>
  <keyword>Vascular</keyword>
  <keyword>cell therapy registry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

